123 related articles for article (PubMed ID: 8386651)
21. The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
Price P; Hogan SJ; Bliss JM; Horwich A
Eur J Cancer; 1990 Apr; 26(4):453-7. PubMed ID: 1694087
[TBL] [Abstract][Full Text] [Related]
22. Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Pagliaro LC
J Clin Oncol; 2017 Apr; 35(10):1036-1040. PubMed ID: 27992270
[TBL] [Abstract][Full Text] [Related]
23. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
[TBL] [Abstract][Full Text] [Related]
24. High dose chemotherapy followed by autologous bone marrow re-infusion in relapsing or refractory testicular cancer.
Sleijfer DT; Mulder PO; de Vries EG; Koops HS; Willemse PH; Sibinga CT; Mulder NH
Prog Clin Biol Res; 1988; 269():429-37. PubMed ID: 2839849
[No Abstract] [Full Text] [Related]
25. Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study.
Kier MG; Lauritsen J; Mortensen MS; Bandak M; Andersen KK; Hansen MK; Agerbaek M; Holm NV; Dalton SO; Johansen C; Daugaard G
Eur Urol; 2017 Feb; 71(2):290-298. PubMed ID: 27649970
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
[TBL] [Abstract][Full Text] [Related]
27. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
28. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
29. [Secondary leukemia following ultra high-dose chemotherapy with peripheral blood stem cell autotransplantation for refractory testicular cancer].
Matsumoto S; Matsuda H; Uejima S; Kurita T
Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):687-91. PubMed ID: 11109821
[TBL] [Abstract][Full Text] [Related]
30. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Droz JP; Biron P
Cancer; 1995 Jul; 76(1):154-5. PubMed ID: 8630870
[No Abstract] [Full Text] [Related]
31. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
Fosså SD; Stenning SP; Gerl A; Horwich A; Clark PI; Wilkinson PM; Jones WG; Williams MV; Oliver RT; Newlands ES; Mead GM; Cullen MH; Kaye SB; Rustin GJ; Cook PA
Br J Cancer; 1999 Jul; 80(9):1392-9. PubMed ID: 10424741
[TBL] [Abstract][Full Text] [Related]
33. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Gilligan T
J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
35. [High-dose chemotherapy with transplantation of autologous stem cells in advanced germ-cell poor-risk testicular tumors].
May M; Georgieva G; Gunia S; Peter N; Steinhauer HB; Hoschke B
Urologiia; 2007; (2):58-63. PubMed ID: 17578200
[TBL] [Abstract][Full Text] [Related]
36. Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial.
Chevreau C; Droz JP; Pico JL; Biron P; Kerbrat P; Cure H; Héron JF; Chevallier B; Fargeot P; Kramar A
Eur Urol; 1993; 23(1):213-7; discussion 218. PubMed ID: 8386652
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in metastatic non-seminomatous germ cell tumours: an interim analysis of the EORTC GU-Group experience.
Stoter G; Sleijfer D; Kaye SB; Jones WG; ten Bokkel Huinink WW; de Pauw M; Sylvester R
Eur Urol; 1993; 23(1):202-6. PubMed ID: 8386650
[TBL] [Abstract][Full Text] [Related]
38. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
39. The growth rate of metastatic non-seminomatous germ cell testicular tumours measured by marker production doubling time--I. Theoretical basis and practical application.
Price P; Hogan SJ; Horwich A
Eur J Cancer; 1990 Apr; 26(4):450-3. PubMed ID: 1694086
[TBL] [Abstract][Full Text] [Related]
40. [A CASE OF ADVANCED NON-SEMINOMATOUS TESTICULAR GERM CELL TUMOR ACCOMPANIED PANIC DISORDER].
Okumura A; Morii A; Kiriyama M; Takamatsu H; Shimizu M; Yasui S; Takagawa K
Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):48-53. PubMed ID: 28132992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
